癌症筛查原则
Principles of Cancer Screening.
作者信息
Pinsky Paul F
机构信息
Division of Cancer Prevention, National Cancer Institute, 9609 Medical Center Drive, Room 5E108, Bethesda, MD 20910, USA.
出版信息
Surg Clin North Am. 2015 Oct;95(5):953-66. doi: 10.1016/j.suc.2015.05.009. Epub 2015 Jun 20.
Abstract
Cancer screening has long been an important component of the struggle to reduce the burden of morbidity and mortality from cancer. Notwithstanding this history, many aspects of cancer screening remain poorly understood. This article presents a summary of basic principles of cancer screening that are relevant for researchers, clinicians, and public health officials alike.
摘要
长期以来，癌症筛查一直是减轻癌症发病率和死亡率负担斗争的重要组成部分。尽管有这样的历史，但癌症筛查的许多方面仍未得到充分理解。本文概述了癌症筛查的基本原则，这些原则对研究人员、临床医生和公共卫生官员同样适用。
相似文献
1
Principles of Cancer Screening.癌症筛查原则
Surg Clin North Am. 2015 Oct;95(5):953-66. doi: 10.1016/j.suc.2015.05.009. Epub 2015 Jun 20.
2
Risks of PSA screening now better understood.前列腺特异性抗原（PSA）筛查的风险现在有了更深入的了解。
J Natl Cancer Inst. 2013 Nov 6;105(21):1590-2. doi: 10.1093/jnci/djt328. Epub 2013 Oct 18.
3
Too Much Medicine: Time to Stop Indiscriminate Cancer Screening.过度医疗：是时候停止不加区分的癌症筛查了。
Ann Acad Med Singap. 2015 Jun;44(6):194-6.
4
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.美国实施数字乳腺摄影后乳腺癌筛查的获益、危害和成本。
J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.
5
Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care Screening.评估在标准护理筛查中增加多项单一癌症检测或一项多癌症检测所产生的假阳性负担和实施成本。
Cancer Med. 2025 Mar;14(6):e70776. doi: 10.1002/cam4.70776.
6
Summaries for Patients. A value framework for cancer screening.患者摘要。癌症筛查的价值框架。
Ann Intern Med. 2015 May 19;162(10). doi: 10.7326/P15-9023.
7
Decision-making methodology for oral mucosal screening.口腔黏膜筛查的决策方法
Dent Today. 2010 May;29(5):68-71; quiz 71.
8
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.基于乳腺癌密度和其他风险因素的个体化乳腺 X 光摄影：健康获益和成本效益分析。
Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.
9
Lung cancer screening: an update, discussion, and look ahead.肺癌筛查：更新、讨论和展望。
Curr Oncol Rep. 2010 Jul;12(4):226-34. doi: 10.1007/s11912-010-0111-6.
10
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.根据乳腺密度和风险调整50岁及以上女性的乳腺癌筛查间隔：筛查结果的协作建模
Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.
引用本文的文献
1
Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions.韩国国家癌症筛查计划的现状：历史、成就与未来方向
J Prev Med Public Health. 2025 Jul;58(4):337-347. doi: 10.3961/jpmph.25.268. Epub 2025 Jun 21.
2
Mixed method analysis of mobile screening clinic for cancer in a tribal community of Maharashtra.马哈拉施特拉邦一个部落社区癌症移动筛查诊所的混合方法分析
J Educ Health Promot. 2025 Jan 31;14:41. doi: 10.4103/jehp.jehp_707_24. eCollection 2025.
3
Navigating the risks: Stakeholder views on risk-based cervical cancer screening.应对风险：利益相关者对基于风险的宫颈癌筛查的看法。
PLoS One. 2025 Mar 5;20(3):e0317986. doi: 10.1371/journal.pone.0317986. eCollection 2025.
4
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study.人乳头瘤病毒阳性口咽癌筛查的影响：一项基于微观模拟的建模研究。
J Natl Cancer Inst. 2025 Jun 1;117(6):1209-1217. doi: 10.1093/jnci/djaf033.
5
Analysis of the Effectiveness and Coverage of Breast, Cervical, and Colorectal Cancer Screening Programs in Kazakhstan for the Period 2021-2023: Regional Disparities and Coverage Dynamics.2021 - 2023年哈萨克斯坦乳腺癌、宫颈癌和结直肠癌筛查项目的有效性及覆盖情况分析：地区差异与覆盖动态
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4371-4380. doi: 10.31557/APJCP.2024.25.12.4371.
6
Estimating the Benefits of Oral Cancer Screening: Challenges and Opportunities.评估口腔癌筛查的益处：挑战与机遇
Cancers (Basel). 2024 Dec 8;16(23):4110. doi: 10.3390/cancers16234110.
7
Women's perspectives on the acceptability of risk-based cervical cancer screening.女性对基于风险的宫颈癌筛查可接受性的看法。
BMC Cancer. 2024 Oct 25;24(1):1314. doi: 10.1186/s12885-024-13050-7.
8
Application of Machine Learning in the Diagnosis of Early Gastric Cancer Using the Kyoto Classification Score and Clinical Features Collected from Medical Consultations.利用京都分类评分和医疗咨询收集的临床特征，将机器学习应用于早期胃癌的诊断
Bioengineering (Basel). 2024 Sep 27;11(10):973. doi: 10.3390/bioengineering11100973.
9
Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two-sample Mendelian randomization study.免疫细胞表型与肺腺癌之间的因果关系：双向两样本孟德尔随机化研究。
Thorac Cancer. 2024 Jul;15(21):1673-1680. doi: 10.1111/1759-7714.15394. Epub 2024 Jun 22.
10
Artificial intelligence in screening and diagnosis of surgical diseases: A narrative review.人工智能在外科疾病筛查与诊断中的应用：一篇综述
AIMS Public Health. 2024 Apr 23;11(2):557-576. doi: 10.3934/publichealth.2024028. eCollection 2024.
本文引用的文献
1
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.结肠镜筛查对结直肠癌发病率和死亡率的影响：一项随机临床试验。
JAMA. 2014 Aug 13;312(6):606-15. doi: 10.1001/jama.2014.8266.
2
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.前列腺癌筛查与死亡率：欧洲前列腺癌筛查随机研究（ERSPC）13年随访结果
Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
3
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.膀胱癌风险：利用前列腺、肺、结直肠癌和卵巢癌筛查试验（PLCO）及国家肺癌筛查试验（NLST）来确定合适的筛查队列。
Urol Oncol. 2015 Feb;33(2):65.e19-25. doi: 10.1016/j.urolonc.2014.06.009. Epub 2014 Jul 16.
4
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.美国实施数字乳腺摄影后乳腺癌筛查的获益、危害和成本。
J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.
5
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.肺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Mar 4;160(5):330-8. doi: 10.7326/M13-2771.
6
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants.利用来自前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验参与者的临床和人口统计学信息预测膀胱癌风险。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2241-9. doi: 10.1158/1055-9965.EPI-13-0632. Epub 2013 Oct 2.
7
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.在前列腺、肺、结肠和卵巢癌筛查（PLCO）试验中前列腺活检后的死亡率和并发症。
BJU Int. 2014 Feb;113(2):254-9. doi: 10.1111/bju.12368. Epub 2013 Nov 21.
8
The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.国家肺癌筛查试验：按人口统计学、吸烟史和肺癌组织学分层的结果。
Cancer. 2013 Nov 15;119(22):3976-83. doi: 10.1002/cncr.28326. Epub 2013 Aug 26.
9
Risk factors for early colonoscopic perforation include non-gastroenterologist endoscopists: a multivariable analysis.非胃肠内镜医生是早期结肠镜穿孔的危险因素：多变量分析。
Clin Gastroenterol Hepatol. 2014 Jan;12(1):85-92. doi: 10.1016/j.cgh.2013.06.030. Epub 2013 Jul 23.
10
Results of initial low-dose computed tomographic screening for lung cancer.肺癌初始低剂量计算机断层扫描筛查结果。
N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.
Zotero 插件